Tech Company Financing Transactions
Incept BioSystems Funding Round
Venture Investors participated in a $3.3 million Series A funding round for Incept BioSystems. The round was announced on 4/26/2007.
Transaction Overview
Company Name
Announced On
4/26/2007
Transaction Type
Venture Equity
Amount
$3,250,000
Round
Series A
Investors
Venture Investors (Lead Investor)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
401 W. Morgan Rd.
Ann Arbor, MI 48108
USA
Ann Arbor, MI 48108
USA
Phone
Website
Email Address
Overview
Incept BioSystems develops innovative microscale and nanoscale technologies that provide cell biologists the ability to obtain high value data about cell growth and behavior. Our technologies were developed to improve the in vitro manipulation, performance, and viability of high-value cells, and our vision is to become the next-generation standard for Premium Cell Management applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Christopher Bleck
Co-Founder
Gary Smith
Co-Founder
Shuichi Takayama
VP - Operations
Jim DellaGatta
VP - R & D
Art Gershowitz
Browse more venture capital transactions:
Prev: 4/26/2007: Ponte Solutions venture capital transaction
Next: 4/26/2007: Cellerant Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs